HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Anders Olsson, John J.V. McMurray, G Thorgeirsson et al. · The Lancet · 1994 · 8.5K citations

Cardiovascular Disease, Health Policy, Hyperlipidemia +8

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

A Keech, R. John Simes, Philip J. Barter et al. · The Lancet · 2005 · 3.2K citations

Diabetes Management, Cardiovascular Disease, Health Policy +9

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Terje R. Pedersen · Atherosclerosis Supplements · 2004 · 3.1K citations

Cardiovascular Disease, Health Policy, Hyperlipidemia +8

Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement Study

Deborah Grady, Nanette K. Wenger, David M. Herrington et al. · Annals of Internal Medicine · 2000 · 714 citations

An Association between Atherosclerosis and Venous Thrombosis

Paolo Prandoni, Franca Bilora, Antonio Marchiori et al. · New England Journal of Medicine · 2003 · 646 citations · Full text